JPMorgan Chase & Co’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.73M Sell
311,937
-12,788
-4% -$276K ﹤0.01% 2487
2025
Q1
$5.39M Sell
324,725
-388,635
-54% -$6.46M ﹤0.01% 2620
2024
Q4
$13.1M Buy
713,360
+272,236
+62% +$5M ﹤0.01% 2046
2024
Q3
$6.78M Sell
441,124
-187,125
-30% -$2.88M ﹤0.01% 2439
2024
Q2
$10.2M Buy
628,249
+153,245
+32% +$2.49M ﹤0.01% 2108
2024
Q1
$8.78M Sell
475,004
-185,896
-28% -$3.44M ﹤0.01% 2198
2023
Q4
$20.7M Buy
660,900
+202,985
+44% +$6.36M ﹤0.01% 1616
2023
Q3
$9.54M Buy
457,915
+176,923
+63% +$3.69M ﹤0.01% 2003
2023
Q2
$6.73M Sell
280,992
-1,303,792
-82% -$31.2M ﹤0.01% 2313
2023
Q1
$29.8M Sell
1,584,784
-510,707
-24% -$9.61M ﹤0.01% 1221
2022
Q4
$33.4M Buy
2,095,491
+236,530
+13% +$3.77M ﹤0.01% 1154
2022
Q3
$30.4M Sell
1,858,961
-47,759
-3% -$781K ﹤0.01% 1165
2022
Q2
$26.9M Sell
1,906,720
-403,635
-17% -$5.69M ﹤0.01% 1248
2022
Q1
$56M Buy
2,310,355
+108,179
+5% +$2.62M 0.01% 1004
2021
Q4
$51.4M Sell
2,202,176
-113,440
-5% -$2.65M 0.01% 1075
2021
Q3
$38.5M Sell
2,315,616
-65,952
-3% -$1.1M ﹤0.01% 1187
2021
Q2
$58.1M Buy
2,381,568
+979,855
+70% +$23.9M 0.01% 1057
2021
Q1
$36.2M Buy
1,401,713
+459,903
+49% +$11.9M ﹤0.01% 1212
2020
Q4
$50.3M Buy
941,810
+71,968
+8% +$3.85M 0.01% 970
2020
Q3
$35.1M Sell
869,842
-206,713
-19% -$8.35M 0.01% 1038
2020
Q2
$52.2M Sell
1,076,555
-20,751
-2% -$1.01M 0.01% 816
2020
Q1
$46.4M Sell
1,097,306
-24,910
-2% -$1.05M 0.01% 776
2019
Q4
$48M Buy
1,122,216
+25,090
+2% +$1.07M 0.01% 883
2019
Q3
$39.5M Sell
1,097,126
-77,637
-7% -$2.79M 0.01% 970
2019
Q2
$31.1M Buy
1,174,763
+367,547
+46% +$9.71M 0.01% 1108
2019
Q1
$21.7M Sell
807,216
-13,955
-2% -$375K ﹤0.01% 1300
2018
Q4
$13.3M Buy
821,171
+10,184
+1% +$165K ﹤0.01% 1502
2018
Q3
$16.8M Buy
810,987
+312,648
+63% +$6.49M ﹤0.01% 1544
2018
Q2
$7.61M Sell
498,339
-1,429,257
-74% -$21.8M ﹤0.01% 1989
2018
Q1
$43.3M Sell
1,927,596
-11,784
-0.6% -$265K 0.01% 934
2017
Q4
$58.4M Buy
1,939,380
+59,556
+3% +$1.79M 0.01% 815
2017
Q3
$72.1M Sell
1,879,824
-3,342
-0.2% -$128K 0.02% 702
2017
Q2
$52.5M Buy
1,883,166
+96,742
+5% +$2.7M 0.01% 815
2017
Q1
$61.4M Sell
1,786,424
-273,408
-13% -$9.4M 0.01% 762
2016
Q4
$59.4M Buy
2,059,832
+505,213
+32% +$14.6M 0.01% 731
2016
Q3
$49.5M Buy
1,554,619
+657,771
+73% +$20.9M 0.01% 773
2016
Q2
$29.1M Sell
896,848
-137,474
-13% -$4.46M 0.01% 1021
2016
Q1
$28.9M Buy
1,034,322
+24,986
+2% +$699K 0.01% 993
2015
Q4
$36M Sell
1,009,336
-6,813
-0.7% -$243K 0.01% 875
2015
Q3
$33.6M Sell
1,016,149
-139,095
-12% -$4.6M 0.01% 897
2015
Q2
$48.4M Sell
1,155,244
-204,444
-15% -$8.56M 0.01% 824
2015
Q1
$44.3M Sell
1,359,688
-135,209
-9% -$4.41M 0.01% 890
2014
Q4
$47.5M Buy
1,494,897
+537,419
+56% +$17.1M 0.01% 866
2014
Q3
$23.7M Buy
957,478
+7,669
+0.8% +$190K 0.01% 1180
2014
Q2
$21.5M Buy
949,809
+107,952
+13% +$2.44M 0.01% 1277
2014
Q1
$20.5M Buy
841,857
+21,658
+3% +$527K 0.01% 1273
2013
Q4
$20.5M Sell
820,199
-71,998
-8% -$1.8M 0.01% 1237
2013
Q3
$24.5M Buy
892,197
+4,665
+0.5% +$128K 0.01% 1134
2013
Q2
$16.1M Buy
+887,532
New +$16.1M 0.01% 1294